Description |
matrin 3 |
5-hydroxytryptamine receptor 2B |
Image |
No pdb structure |
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
|
- Proportion of activated microglia (midfrontal cortex) ( 30679421)
- Thiazide-induced adverse metabolic effects in hypertensive patients ( 23400010)
|
Interacting Genes |
100 interacting genes:
AIMP2
AKTIP
CALM1
CDC42
EGFR
ERG
GFI1B
HNRNPK
HTR2B
KRT27
KRT34
LINC01232
LMNA
MIR1-1
MIR1-2
MIR106A
MIR106B
MIR107
MIR10B
MIR122
MIR128-1
MIR128-2
MIR138-1
MIR138-2
MIR140
MIR141
MIR143
MIR145
MIR155
MIR15A
MIR15B
MIR16-1
MIR16-2
MIR17
MIR18A
MIR18B
MIR199A1
MIR199A2
MIR19A
MIR19B1
MIR19B2
MIR200A
MIR200B
MIR200C
MIR205
MIR206
MIR20A
MIR20B
MIR21
MIR214
MIR221
MIR222
MIR25
MIR29A
MIR29B1
MIR29B2
MIR29C
MIR31
MIR34A
MIR34B
MIR34C
MIR363
MIR429
MIR451A
MIR7-1
MIR7-2
MIR7-3
MIR9-1
MIR9-2
MIR9-3
MIR92A1
MIR92A2
MIR93
MIR98
MIRLET7A1
MIRLET7A2
MIRLET7A3
MIRLET7B
MIRLET7C
MIRLET7D
MIRLET7E
MIRLET7F1
MIRLET7F2
MIRLET7G
MIRLET7I
PCBP1
PCBP3
PLEKHG4
PTBP2
PTEN
RASD1
SNAP23
SNRNP200
SRPK2
TNFRSF21
TRAF1
TRAF6
TSGA10
TTF2
UBE2I
|
27 interacting genes:
ABCA3
ATP1B1
BNIP3
BNIP3L
CBR1
CHPT1
G6PC3
GNA11
GNAQ
HAT1
HDGFL2
INSIG1
KIF19
LNX1
MATR3
METRN
NAT14
NIPA2
OAZ1
PLLP
PPP1R3F
RAE1
SLC31A2
SLC37A1
SLC44A2
SNTA1
TRAM1L1
|
Entrez ID |
9782 |
3357 |
HPRD ID |
05270 |
03077 |
Ensembl ID |
ENSG00000015479
|
ENSG00000135914
|
Uniprot IDs |
A0A0R4J2E8
B3KM87
B4DF66
P43243
Q9H4N1
|
P41595
|
PDB IDs |
|
4IB4
4NC3
5TUD
5TVN
6DRX
6DRY
6DRZ
6DS0
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|